Thank you, Madam Chair.
To Mr. Mazier's point, I believe the order you're referring to is for questions, not for motions. I'd just like to put that on the record as well.
I also want to add my support to what my colleague, Dr. Powlowski, was just referring to in terms of an opioid study, because it's such an important issue impacting so many families. I just want to add my support to that.
My last comment is on my motion to the committee, the pharmaceutical sovereignty piece. I think we've seen over and over again the importance of having that as we move forward and plan ahead. It's just to support the families across the country so that they no longer have to scramble for resources and pharmaceutical products. I just want to really emphasize the importance of that.